| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 162.35B | 156.17B | 133.62B | 131.70B | 114.49B |
| Gross Profit | 40.78B | 42.16B | 20.95B | 18.24B | 30.45B |
| EBITDA | 42.47B | 43.21B | 26.34B | 22.58B | 32.89B |
| Net Income | 22.64B | 22.37B | 11.46B | 8.70B | 16.07B |
Balance Sheet | |||||
| Total Assets | 245.48B | 229.17B | 200.32B | 185.74B | 188.42B |
| Cash, Cash Equivalents and Short-Term Investments | 62.41B | 44.77B | 31.72B | 27.38B | 49.23B |
| Total Debt | 72.53B | 71.84B | 63.86B | 59.74B | 60.41B |
| Total Liabilities | 103.71B | 110.55B | 94.06B | 89.44B | 95.98B |
| Stockholders Equity | 132.65B | 107.80B | 92.24B | 84.50B | 81.31B |
Cash Flow | |||||
| Free Cash Flow | 27.84B | 21.15B | 15.13B | -2.66B | 21.99B |
| Operating Cash Flow | 39.00B | 33.98B | 22.40B | 7.62B | 28.65B |
| Investing Cash Flow | -22.49B | -12.56B | -17.89B | -16.77B | -5.46B |
| Financing Cash Flow | -10.14B | -8.43B | -199.58M | -12.79B | -19.40B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$210.32B | 7.66 | 19.96% | 3.32% | 1.76% | 2.25% | |
70 Outperform | HK$313.81B | 12.29 | 24.18% | 5.10% | 3.98% | 0.89% | |
62 Neutral | HK$19.97B | ― | 25.82% | 1.46% | ― | ― | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
58 Neutral | HK$3.20B | 4.46 | 10.36% | 8.68% | 9.91% | -23.35% | |
52 Neutral | HK$880.30M | 5.45 | 3.46% | ― | 15.05% | -45.24% | |
46 Neutral | HK$155.92M | -2.68 | -0.58% | ― | -60.77% | -310.68% |